Aurelia Healthcare Business Plan › Section 3 › Market Opportunity & Industry Analysis

3.1 South African Healthcare System — Structural Overview

South Africa operates a uniquely bifurcated healthcare system. A
predominantly tax-funded public sector serves approximately 84% of the
population through 422 public hospitals, while a sophisticated private
sector — comprising 203 private hospitals, an extensive network of GPs
and specialists, three publicly-listed hospital operators, two listed
pathology majors, and a robust medical-scheme funding ecosystem — serves
the remaining 16% (predominantly insured) population. Approximately 80%
of South Africa’s registered medical practitioners practise primarily in
the private sector.

This bifurcation produces both the opportunity and the constraint
that defines Aurelia’s strategy. The constraint: an insured market of
approximately 9 million members places quantitative limits on
private-sector revenue scaling. The opportunity: chronic public-sector
capacity shortfalls, persistent tertiary specialist shortages, and
emerging National Health Insurance (NHI) contracting frameworks create
structural overflow, public-private partnership, and addressable
middle-market expansion vectors that established operators have only
partially captured.

Figure 3.1

3.2 Market Size & Growth Trajectory

The South African healthcare market is projected to grow from
approximately USD 41.8 billion (2024) to USD 55.2 billion by 2029, with
the hospital services sub-segment forecast to reach USD 9.04 billion by
2029 at a CAGR of 2.25% (2025–2029) per Statista. The broader healthcare
opportunity, including pharmaceuticals, diagnostics, medical devices,
and digital health, is forecast to reach USD 47.1 billion by 2027 per
ResearchAndMarkets analysis.

Within this aggregate, several sub-segments exhibit materially higher
growth dynamics than the headline figure: hospital supplies (CAGR 6.76%
to USD 1.23 billion by 2030), specialty clinics & day surgery (CAGR
7.14%), advanced sterilisation (CAGR 8.29%), and medical devices (CAGR
8.97%). These sub-segment dynamics inform Aurelia’s emphasis on tertiary
specialty acuity, day-care infrastructure, and technology-enabled
services as primary value pools.

Figure 3.2

3.3 Structural Demand Drivers

Aurelia’s investment thesis rests on a confluence of structurally
durable demand drivers, each independently capable of underwriting a
multi-decade growth trajectory and collectively reinforcing.

(i) Chronic & Non-Communicable Disease Burden.
South Africa carries the world’s highest absolute HIV/AIDS burden,
alongside rapidly rising rates of diabetes (estimated 4.5 million
adults), hypertension (~13 million), and cancer (~110,000 new diagnoses
annually). The non-communicable disease (NCD) burden in particular
drives sustained demand for cardiology, oncology, renal services, and
chronic-disease management.

(ii) Demographic Aging. The over-65 population is
forecast to grow from approximately 3.4 million (2024) to 5.8 million by
2040. Older patients consume disproportionately higher volumes of
cardiac, orthopaedic, oncology, and surgical services — directly aligned
with Aurelia’s service mix.

(iii) Public Sector Overflow. Public hospitals
operate with material capacity, equipment, and clinician shortfalls.
Wait times for elective surgery in major public tertiary hospitals
routinely exceed 12 months for joint replacement and 6–9 months for
cardiac surgery, generating strong out-of-pocket and corporate-sponsored
overflow into private facilities.

(iv) Medical Scheme Membership Stability. Medical
scheme membership remained stable around 9 million principal members and
dependants through 2024–2025, with Discovery Health Medical Scheme (~3.6
million lives), Government Employees Medical Scheme (GEMS, ~2.2 million
lives), and Bonitas (~700,000 lives) the largest payers. Schemes
implemented contribution increases of 9.3%–12.75% for 2025, validating
sustained willingness to pay for private healthcare.

(v) Medical Tourism Inflow. South Africa serves as
the regional tertiary destination for the SADC bloc — Botswana, Namibia,
Lesotho, eSwatini, Zimbabwe, Mozambique, Angola, Zambia — with
significant cross-border patient flow into Johannesburg, Pretoria, and
Cape Town for cardiac surgery, oncology, and complex orthopaedic
procedures. International medical tourism (UK, Middle East, sub-Saharan
Africa for executive health) represents an additional 4–6% of premium
revenue at established operators.

(vi) NHI Contracting Opportunity. The NHI Act 20 of
2023, signed into law on 15 May 2024 and currently in Phase 1
(2023–2026), envisages a single-payer system that will purchase services
from accredited public AND private providers. Even with a multi-decade
implementation timeline, NHI contracting opens material new patient flow
into accredited private hospitals — and Aurelia’s greenfield design
positions it for early accreditation.

Figure 3.3

3.4 Competitive Landscape

The private hospital market is highly concentrated. Per the
Competition Commission Health Market Inquiry, three operators — Netcare,
Mediclinic Southern Africa, and Life Healthcare — collectively
controlled approximately 83% of private hospital beds and 90% of
admissions. While this concentration historically reflected limited
contestability, the maturation of the regulatory environment, the NHI
Act’s explicit anticipation of new accredited private providers, and the
chronic under-supply of certain specialty services have created
opportunities for differentiated new entrants.

Figure 3.4

Direct Competitors

Strategic Positioning

Aurelia is positioned in the upper-right quadrant of the strategic
positioning matrix — high specialty depth, broad service offering —
alongside the major academic public hospitals and the premium tertiary
segments of Netcare and Mediclinic. Critically, Aurelia’s greenfield
design allows it to deliver this positioning with materially lower
operating cost per bed than legacy competitors, owing to modern facility
design, integrated EMR, AI-augmented workflows, and centralised
back-office shared services.

Figure 3.5

3.5 Regulatory Environment

National Health Insurance (NHI) Act

The NHI Act 20 of 2023 was signed into law by President Cyril
Ramaphosa on 15 May 2024 and gazetted on 16 May 2024. The Act envisages
a single-payer National Health Insurance Fund as the primary purchaser
of healthcare services on behalf of all eligible South African
residents, with Phase 1 (2023–2026) focused on institutional
capacity-building and Phase 2 (2026–2028) on initial scaled service
delivery.

As of November 2025, the President has not proclaimed an effective
date for the operative provisions of the Act, and several constitutional
and legislative challenges remain pending. The Discovery Health Medical
Scheme — the largest scheme in the country — has publicly assessed full
implementation as a multi-decade horizon, citing structural funding
gaps. Aurelia’s base case assumes:

• NHI contracting framework operational from approximately
  2027–2028 with selective accreditation of private
  hospitals.
• Medical schemes continue to operate with overlapping
  coverage for the foreseeable horizon (10–20 years), as confirmed by the
  Minister of Health and consistent with international precedent in
  countries with national health insurance.
• No removal of medical scheme tax credits in the
  near-term modelling horizon (Years 1–5); modest erosion modelled in
  stress scenarios.
• NHI tariffs at approximately 70%–80% of current medical
  scheme reference prices for accredited services — Aurelia is
  engineered to operate profitably even at NHI tariff levels owing to its
  modern cost structure.

Council for Medical Schemes (CMS) Regulation

The CMS regulates medical scheme contributions, prescribed minimum
benefits (PMBs), and solvency. Schemes are required to maintain solvency
ratios of at least 25%; 2024 industry weighted-average solvency was
approximately 41%, indicating a financially robust funder base. The 271
PMB conditions and 27 chronic-disease list conditions form the floor of
cover that all schemes must provide — these are highly aligned with
Aurelia’s tertiary acuity mix (cardiac, oncology, trauma, renal).

Office of Health Standards Compliance (OHSC) & COHSASA

All private hospitals must register with the OHSC and demonstrate
compliance with the National Core Standards. Voluntary accreditation by
the Council for Health Service Accreditation of Southern Africa
(COHSASA) is the de-facto standard for medical-scheme contracting.
Aurelia has budgeted for full COHSASA accreditation prior to
commissioning of each facility, with a target of additional Joint
Commission International (JCI) accreditation for the flagship within 24
months of opening — supporting medical tourism and premium
positioning.

Health Professions Council of South Africa (HPCSA)

The HPCSA registers all medical practitioners and regulates scope of
practice. Aurelia’s clinician-engagement model uses standard “right of
admission” affiliation contracts (not employment) for specialists in
line with industry norms — this preserves clinician autonomy and
tariff-billing rights, while affording Aurelia governance over clinical
pathways, quality metrics, and infrastructure utilisation.

3.6 Payer Mix Strategy

Aurelia targets a deliberately diversified payer mix to reduce
concentration risk and capture the full demand spectrum. The base case
assumes evolution of payer composition as follows:

Figure 3.6

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Aurelia Healthcare Holdings (Pty) Ltd.